Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Biasoni

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Clinical Genitourinary Cancer|January 8, 2014
Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancerAndrea Necchi, Luigi Mariani, Patrizia Giannatempo, et al.
Cancer|January 12, 2013
Synchronous bilateral Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)Paolo Indolfi, Alessandro Jenkner, Monica Terenziani, et al.
The Journal of Urology|October 2, 2017
Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume CenterNicola Nicolai, Nicholas Tarabelloni, Francesca Gasperoni, et al.
Tumori|June 6, 2015
Quality of life and pain control following laparoscopic retroperitoneal lymph node dissection in early-stage nonseminomaNicola Nicolai, Elisabetta Bianchi, Ilaria Donati, et al.
Urologic Oncology|March 3, 2023
Bilateral inguinal lymph-node dissection vs. unilateral inguinal lymph-node dissection and dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penisSebastiano Nazzani, Mario Catanzaro, Davide Biasoni, et al.
Clinical Genitourinary Cancer|March 2, 2015
Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral CenterAndrea Necchi, Elena Farè, Salvatore Lo Vullo, et al.
The Journal of Urology|June 29, 2017
Results of the Third AIEOP Cooperative Protocol on Wilms Tumor (TW2003) and Related ConsiderationsFilippo Spreafico, Davide Biasoni, Salvatore Lo Vullo, et al.
Clinical Genitourinary Cancer|January 26, 2024
Surveillance or Dynamic Sentinel Lymph-Node Biopsy in Low-Risk Clinically N0 Penile Squamous Cell Carcinoma: Single-Institution Real World DataSebastiano Nazzani, Mario Catanzaro, Martina Bruniera, et al.
BJU International|September 19, 2017
First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 studyAndrea Necchi, Salvatore Lo Vullo, Federica Perrone, et al.
Urologic Oncology|September 16, 2017
Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 studyAndrea Necchi, Salvatore Lo Vullo, Daniele Raggi, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Clinical Genitourinary Cancer|January 8, 2014
Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancerAndrea Necchi, Luigi Mariani, Patrizia Giannatempo, et al.
Cancer|January 12, 2013
Synchronous bilateral Wilms tumor: a report from the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)Paolo Indolfi, Alessandro Jenkner, Monica Terenziani, et al.
The Journal of Urology|October 2, 2017
Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume CenterNicola Nicolai, Nicholas Tarabelloni, Francesca Gasperoni, et al.
Tumori|June 6, 2015
Quality of life and pain control following laparoscopic retroperitoneal lymph node dissection in early-stage nonseminomaNicola Nicolai, Elisabetta Bianchi, Ilaria Donati, et al.
Urologic Oncology|March 3, 2023
Bilateral inguinal lymph-node dissection vs. unilateral inguinal lymph-node dissection and dynamic sentinel node biopsy in clinical N1 squamous cell carcinoma of the penisSebastiano Nazzani, Mario Catanzaro, Davide Biasoni, et al.
Clinical Genitourinary Cancer|March 2, 2015
Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral CenterAndrea Necchi, Elena Farè, Salvatore Lo Vullo, et al.
The Journal of Urology|June 29, 2017
Results of the Third AIEOP Cooperative Protocol on Wilms Tumor (TW2003) and Related ConsiderationsFilippo Spreafico, Davide Biasoni, Salvatore Lo Vullo, et al.
Clinical Genitourinary Cancer|January 26, 2024
Surveillance or Dynamic Sentinel Lymph-Node Biopsy in Low-Risk Clinically N0 Penile Squamous Cell Carcinoma: Single-Institution Real World DataSebastiano Nazzani, Mario Catanzaro, Martina Bruniera, et al.
BJU International|September 19, 2017
First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 studyAndrea Necchi, Salvatore Lo Vullo, Federica Perrone, et al.
Urologic Oncology|September 16, 2017
Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 studyAndrea Necchi, Salvatore Lo Vullo, Daniele Raggi, et al.
Pageof 7